JP2019068846A5 - - Google Patents

Download PDF

Info

Publication number
JP2019068846A5
JP2019068846A5 JP2019000688A JP2019000688A JP2019068846A5 JP 2019068846 A5 JP2019068846 A5 JP 2019068846A5 JP 2019000688 A JP2019000688 A JP 2019000688A JP 2019000688 A JP2019000688 A JP 2019000688A JP 2019068846 A5 JP2019068846 A5 JP 2019068846A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019000688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019068846A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019068846A publication Critical patent/JP2019068846A/ja
Publication of JP2019068846A5 publication Critical patent/JP2019068846A5/ja
Pending legal-status Critical Current

Links

JP2019000688A 2007-03-14 2019-01-07 ウイルス様粒子の精製 Pending JP2019068846A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90682107P 2007-03-14 2007-03-14
US60/906,821 2007-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017032171A Division JP2017086090A (ja) 2007-03-14 2017-02-23 ウイルス様粒子の精製

Publications (2)

Publication Number Publication Date
JP2019068846A JP2019068846A (ja) 2019-05-09
JP2019068846A5 true JP2019068846A5 (cg-RX-API-DMAC10.html) 2019-10-24

Family

ID=39760420

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009553820A Active JP5284290B2 (ja) 2007-03-14 2008-03-14 ウイルス様粒子の精製
JP2013112580A Pending JP2013176392A (ja) 2007-03-14 2013-05-29 ウイルス様粒子の精製
JP2017032171A Pending JP2017086090A (ja) 2007-03-14 2017-02-23 ウイルス様粒子の精製
JP2019000688A Pending JP2019068846A (ja) 2007-03-14 2019-01-07 ウイルス様粒子の精製

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2009553820A Active JP5284290B2 (ja) 2007-03-14 2008-03-14 ウイルス様粒子の精製
JP2013112580A Pending JP2013176392A (ja) 2007-03-14 2013-05-29 ウイルス様粒子の精製
JP2017032171A Pending JP2017086090A (ja) 2007-03-14 2017-02-23 ウイルス様粒子の精製

Country Status (12)

Country Link
US (4) US8481693B2 (cg-RX-API-DMAC10.html)
EP (1) EP2134360B1 (cg-RX-API-DMAC10.html)
JP (4) JP5284290B2 (cg-RX-API-DMAC10.html)
KR (3) KR20150098681A (cg-RX-API-DMAC10.html)
AU (1) AU2008224877B2 (cg-RX-API-DMAC10.html)
CA (1) CA2683977C (cg-RX-API-DMAC10.html)
DK (1) DK2134360T3 (cg-RX-API-DMAC10.html)
ES (1) ES2559421T3 (cg-RX-API-DMAC10.html)
HU (1) HUE028605T2 (cg-RX-API-DMAC10.html)
PL (1) PL2134360T3 (cg-RX-API-DMAC10.html)
SG (2) SG10201701988TA (cg-RX-API-DMAC10.html)
WO (1) WO2008113011A2 (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2641613A1 (en) 2006-09-29 2013-09-25 Ligocyte Pharmaceuticals, Inc. Liquid norovirus vaccine formulations comprising toll-like receptor (TLR) agonist as adjuvant
KR20150098681A (ko) 2007-03-14 2015-08-28 다케다 백신즈 인코포레이티드 바이러스 유사 입자 정제
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
TR201815937T4 (tr) 2009-06-16 2018-11-21 Genzyme Corp Rekombinant AAV vektörlerinin purifikasyonu için geliştirilen yöntemler.
WO2011000058A1 (en) * 2009-07-03 2011-01-06 The University Of Queensland A method of preparation of a biological particulate structure
US20110142863A1 (en) * 2009-12-16 2011-06-16 Millipore Corporation Flow through purification processes for large biomolecules
JP5773454B2 (ja) 2010-01-15 2015-09-02 バイオ−ラッド ラボラトリーズ インコーポレーティッド アパタイトの表面中和方法
JP2013523175A (ja) * 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
DE102010046817A1 (de) * 2010-09-28 2012-03-29 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium
FI122520B (fi) * 2010-10-15 2012-03-15 Vesna Blazevic Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena
US9592540B2 (en) 2011-02-02 2017-03-14 Bio-Rad Laboratories, Inc. Apatite surface neutralization with alkali solutions
MX379496B (es) 2011-07-11 2025-03-11 Takeda Vaccines Inc Formulaciones parenterales de vacunas contra los norovirus.
EP2554664A1 (de) * 2011-08-02 2013-02-06 Life Science Inkubator Verfahren zur Aufreinigung von Virus-ähnlichen Partikeln (VLP)
JP2015503915A (ja) * 2011-12-30 2015-02-05 ドイチェス クレブスフォルシュンクスツェントルム ワクチン接種目的のためのエプスタイン・バーウイルス由来の第二世代ウイルス様粒子(vlp)
EP2855501B1 (en) * 2012-05-30 2018-04-25 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
JOP20130186B1 (ar) * 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
US9902942B2 (en) 2013-02-22 2018-02-27 Agency For Science, Technology And Research Chromatographic purification of virus preparations with negatively charged particles
JP2015015931A (ja) * 2013-07-12 2015-01-29 株式会社Umnファーマ ウイルス様粒子を含む培養物の製造方法
JP6479305B2 (ja) 2013-07-12 2019-03-06 株式会社Umnファーマ ウイルス様粒子の精製方法
JP2015017065A (ja) * 2013-07-12 2015-01-29 株式会社Umnファーマ ノロウイルスのウイルス様粒子を含む医薬組成物
EP3052631B1 (en) 2013-10-03 2019-08-07 Takeda Vaccines, Inc. Methods of detection and removal of rhabdoviruses from cell lines
WO2015200299A2 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
EP3157689B1 (en) 2014-06-23 2021-04-28 Bio-Rad Laboratories, Inc. Apatite pretreatment
CN107603959A (zh) * 2017-08-30 2018-01-19 四川大学 提高缓冲液盐离子浓度纯化病毒的方法
AU2018379811B2 (en) * 2017-12-07 2024-04-11 Emp Biotech Gmbh System and method of applied radial technology chromatography
JP6704074B2 (ja) * 2019-02-04 2020-06-03 株式会社Umnファーマ ウイルス様粒子の精製方法
EP3995504A4 (en) * 2019-07-04 2023-07-12 Kaneka Corporation PROCEDURE FOR PURIFICATION OF VIRUS OR VIRUS-LIKE PARTICLES
EP4206329A4 (en) * 2020-08-28 2024-11-20 Kaneka Corporation Method for purifying useful substance
EP4225462A1 (en) * 2020-10-05 2023-08-16 Sartorius BIA Separations d.o.o. Improved removal of rna and contaminants from dna plasmid preparations by hydrophobic interaction chromatography
AU2022217587A1 (en) * 2021-02-02 2023-08-17 C. I. TAKIRON Corporation Solar power generation system and reflector for solar power generation system
JP2024519800A (ja) 2021-05-21 2024-05-21 タケダ ワクチン,インコーポレイテッド 固体組成物、フリーズドライ方法およびガラスバイアル
WO2025077807A1 (en) * 2023-10-12 2025-04-17 Chengdu Kanghua Biological Products Co., Ltd. Methods for obtaining high-purity norovirus virus-like particles (vlps)
WO2025077800A1 (en) * 2023-10-12 2025-04-17 Chengdu Kanghua Biological Products Co., Ltd. Purification of norovirus virus-like particles (vlps)

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2833106B2 (ja) 1990-02-21 1998-12-09 株式会社島津製作所 液体クロマトグラフ
WO1994026087A2 (en) 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
PT757717E (pt) * 1994-05-16 2006-09-29 Merck & Co Inc Vacinas de papilomavirus
AR004464A1 (es) 1994-11-14 1998-12-16 Merck Sharp & Dohme Un metodo para producir una proteina de capside de papilomavirus
JP3316325B2 (ja) 1994-12-20 2002-08-19 富士シリシア化学株式会社 ビール安定化処理用シリカゲル及びその製造方法並びにビールの安定化処理方法
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2269097C (en) 1996-11-08 2007-01-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
ES2572628T3 (es) * 1997-09-05 2016-06-01 Medimmune, Inc. Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
DE19823814A1 (de) * 1998-05-27 1999-12-02 Octapharma Ag Ziegelbruecke Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie
ES2262333T3 (es) * 1998-08-14 2006-11-16 MERCK & CO., INC. Procedimiento para purificar particulas similares a virus de papilomavirus humano.
US6349843B1 (en) 1999-04-01 2002-02-26 The Vollrath Company Llc Pan removal ramp
AU768992B2 (en) * 1999-06-22 2004-01-15 Denka Seiken Co., Ltd. SRSV detection kit
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP2003066021A (ja) 2001-08-28 2003-03-05 Hiroshi Shionoya 連続分取液体クロマトグラフィー装置とそれを用いる方法
WO2003068163A2 (en) * 2002-02-14 2003-08-21 Novavax, Inc. Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
KR100788093B1 (ko) * 2002-04-26 2007-12-21 제넨테크, 인크. 단백질의 비친화성 정제
CA2496918A1 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
US7879338B2 (en) * 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
US7481997B1 (en) * 2004-02-12 2009-01-27 Montana State University Snow mountain virus genome sequence, virus-like particles and methods of use
WO2006138514A2 (en) * 2005-06-16 2006-12-28 Children's Hospital Medical Center Novel norovirus particle for use as an antiviral or vaccine
EP1736538A1 (en) * 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
CA2630220C (en) * 2005-11-22 2020-10-13 Doris Coit Norovirus and sapovirus antigens
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
AU2007345768B2 (en) 2006-07-27 2013-08-01 Ligocyte Pharmaceuticals, Inc. Chimeric influenza virus-like particles
EP2641613A1 (en) 2006-09-29 2013-09-25 Ligocyte Pharmaceuticals, Inc. Liquid norovirus vaccine formulations comprising toll-like receptor (TLR) agonist as adjuvant
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
KR20150098681A (ko) 2007-03-14 2015-08-28 다케다 백신즈 인코포레이티드 바이러스 유사 입자 정제
EP2027875A1 (en) 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
US10130696B2 (en) 2007-09-18 2018-11-20 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
EP2235165A1 (en) 2007-12-21 2010-10-06 Cytos Biotechnology AG Process for clarifying cell homogenates
EP3382011A1 (en) * 2008-08-08 2018-10-03 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
US20110262483A1 (en) 2008-11-03 2011-10-27 Ligocyte Pharmaceuticals, Inc. Methods for isolating enveloped virus-based vlps free of infectious agents
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
SG182636A1 (en) * 2010-01-21 2012-08-30 Ligocyte Pharmaceuticals Inc Targeted heterologous antigen presentation on calicivirus virus-like particles
EP2619217B1 (en) 2010-09-20 2016-11-09 Bio-Rad Laboratories, Inc. Dissociation of product-complexed contaminants in chromatography
FI122520B (fi) 2010-10-15 2012-03-15 Vesna Blazevic Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena
CN102260651A (zh) 2011-06-24 2011-11-30 华中科技大学同济医学院附属协和医院 一种纯化病毒样颗粒蛋白的方法及其应用
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
JP2015015931A (ja) 2013-07-12 2015-01-29 株式会社Umnファーマ ウイルス様粒子を含む培養物の製造方法

Similar Documents

Publication Publication Date Title
JP2019068846A5 (cg-RX-API-DMAC10.html)
JP2021028398A5 (cg-RX-API-DMAC10.html)
JP2023116721A5 (cg-RX-API-DMAC10.html)
JP2022028828A5 (cg-RX-API-DMAC10.html)
JP2022025124A5 (cg-RX-API-DMAC10.html)
JP2020042034A5 (cg-RX-API-DMAC10.html)
JP2021185136A5 (cg-RX-API-DMAC10.html)
JP2021169491A5 (cg-RX-API-DMAC10.html)
JP2019099571A5 (cg-RX-API-DMAC10.html)
JP2019030304A5 (cg-RX-API-DMAC10.html)
JP2021502066A5 (cg-RX-API-DMAC10.html)
JP2020530297A5 (cg-RX-API-DMAC10.html)
JP2020007340A5 (cg-RX-API-DMAC10.html)
JP2020040981A5 (cg-RX-API-DMAC10.html)
JP2020534795A5 (cg-RX-API-DMAC10.html)
JP2020010717A5 (cg-RX-API-DMAC10.html)
JP2021038271A5 (cg-RX-API-DMAC10.html)
JP2018154848A5 (cg-RX-API-DMAC10.html)
JP2018135352A5 (cg-RX-API-DMAC10.html)
JP2019031552A5 (cg-RX-API-DMAC10.html)
JP2019142968A5 (cg-RX-API-DMAC10.html)
JPWO2020148954A5 (cg-RX-API-DMAC10.html)
JP2024016014A5 (cg-RX-API-DMAC10.html)
JP2017214405A5 (cg-RX-API-DMAC10.html)
JP2016196495A5 (cg-RX-API-DMAC10.html)